The Evolution of Immunotherapy Against Tumors: An Historical Approach
Autor Domenico Ribattien Limba Engleză Paperback – 30 aug 2024
The immune system plays a major role in the surveillance against tumors. To avoid attack from the immune system, tumor cells develop different strategies to escape immune surveillance. Evidence of immune surveillance comes from both animal models and clinical observations. Mice with a wide variety of immunodeficiencies have a high rate of tumor incidence and are more susceptible to transplanted or chemical carcinogen-induced tumors. Immunosuppressed patients have a high incidence of tumors. However, many patients develop cancer even in the presence of an apparently normal immune system. This indicates that tumor cells can escape immune surveillance.
- Covers the experimental approaches to investigate immunotherapy against tumors
- Provides a comprehensive overview of the pharmacological tools in this field
- Serves as a reference book to researchers in the respective fields and related disciplines
Preț: 818.37 lei
Preț vechi: 877.33 lei
-7% Nou
Puncte Express: 1228
Preț estimativ în valută:
156.61€ • 162.58$ • 130.59£
156.61€ • 162.58$ • 130.59£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443217982
ISBN-10: 044321798X
Pagini: 194
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 044321798X
Pagini: 194
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
Immunosurveillance against tumors
Immunoediting
Basic immunotherapy with IL-2
Adoptive T cell therapy
DNA vaccines
Dendritic cell (DC) vaccines
Antibody therapy
Co-applying anti-angiogenic and immune checkpoints inhibitors
Conclusions
Immunoediting
Basic immunotherapy with IL-2
Adoptive T cell therapy
DNA vaccines
Dendritic cell (DC) vaccines
Antibody therapy
Co-applying anti-angiogenic and immune checkpoints inhibitors
Conclusions